Advertisement |
 |
QUINTILES COMPREHENSIVE CANCER PANEL. A targeted sequencing assay for simultaneous analysis of genomic variation, which may be predictive of response to multiple therapies in clinical development. Identifies pathways, markers of disease and unique variant types to select for patient populations likely to benefit from targeted therapies. Learn More. | | | |
 |
 |
TABLE OF CONTENTS |
April 2015 Volume 33, Issue 4 |
 |  |  |
 | Editorial News Bioentrepreneur Opinion and Comment Features News and Views Computational Biology Research Careers and Recruitment
|  | Advertisement |  |  |  | Protein expression & purification—learn practical production tips from experts
A centralized place to expand your knowledge on every step of protein expression and purification.
Get free access NOW | | |
| |
 |
|
 |
 |
Advertisement |
 |
|
 |
|
Editorial | Top |
 |
 |
 |
Rebooting review p319 doi:10.1038/nbt.3202 Nature Biotechnology is reevaluating editorial oversight of papers centered on computational analyses in anticipation of the 'big data' world.
|
 |
News | Top |
 |
 |
 |
IDO inhibitors move center stage in immuno-oncology pp321 - 322 Cormac Sheridan doi:10.1038/nbt0415-321
|
 |
 |
 |
Apple's ResearchKit frees medical research p322 doi:10.1038/nbt0415-322
|
 |
 |
 |
Pfizer's CDK4/6 inhibitor approved for advanced breast cancer pp323 - 324 Chris Morrison doi:10.1038/nbt0415-323
|
 |
 |
 |
NIH innovation investment pays p324 doi:10.1038/nbt0415-324
|
 |
 |
 |
Obama catapults patient-empowered Precision Medicine p325 Jeffrey L Fox doi:10.1038/nbt0415-325
|
 |
 |
 |
Bavarian Nordic's prostate vaccine hits pay dirt p326 doi:10.1038/nbt0415-326a
|
 |
 |
 |
20-year-old EMA's birthday bash p326 doi:10.1038/nbt0415-326b
|
 |
 |
 |
Nonbrowning GM apple cleared for market pp326 - 327 Emily Waltz doi:10.1038/nbt0415-326c
|
 |
 |
 |
Around the world in a month p327 doi:10.1038/nbt0415-327
|
 |
 |
 |
Monsanto adds dicamba to its cache to counter weed threat p328 Emily Waltz doi:10.1038/nbt0415-328
|
 |
 |
 |
News Feature |
 |
 |
 |
Engineers of scent pp329 - 332 Emily Waltz doi:10.1038/nbt.3191 Companies exploring biotech approaches to flavor and fragrance production must navigate challenges in regulations, market dynamics and public perception. Emily Waltz investigates.
|
 |
Bioentrepreneur | Top |
 |
 |
 |
Datapage |
 |
 |
 |
Academic partnerships 2014 p333 Brady Huggett doi:10.1038/nbt.3189
|
 |
 |
 |
Podcast |
 |
 |
 |
First Rounders Podcast: Kari Stefansson p333 doi:10.1038/nbt.3186
|
 |
Opinion and Comment | Top |
 |
 |
 |
Correspondence |
 |
 |
 |
The quintessence of immunogenicity reporting for biotherapeutics pp334 - 336 Gopi Shankar, Steven Arkin, Viswanath Devanarayan, Arno Kromminga, Valerie Quarmby et al. doi:10.1038/nbt.3181
|
 |
 |
 |
Silence on the relevant literature and errors in implementation pp336 - 339 Philippe Bastiaens, Marc R Birtwistle, Nils Bluthgen, Frank J Bruggeman, Kwang-Hyun Cho et al. doi:10.1038/nbt.3185
|
 |
 |
 |
Response to Letter of Correspondence - Bastiaens et al. pp339 - 342 Baruch Barzel and Albert-Laszlo Barabasi doi:10.1038/nbt.3184
|
 |
 |
 |
Opportunities for drug repositioning from phenome-wide association studies pp342 - 345 Majid Rastegar-Mojarad, Zhan Ye, Jill M Kolesar, Scott J Hebbring and Simon M Lin doi:10.1038/nbt.3183
|
 |
 |
 |
Epigenomic annotation of genetic variants using the Roadmap Epigenome Browser pp345 - 346 Xin Zhou, Daofeng Li, Bo Zhang, Rebecca F Lowdon, Nicole B Rockweiler et al. doi:10.1038/nbt.3158
|
 |
Features | Top |
 |
 |
 |
Patents |
 |
 |
 |
Are the gene-patent storm clouds dissipating? A global snapshot pp347 - 352 Johnathon Liddicoat, Tess Whitton and Dianne Nicol doi:10.1038/nbt.3182 In genetic diagnostics testing, what are the boundaries of the global patent problem, and is there a real risk that patents and licensing practices could impede access to tests?
|
 |
 |
 |
Recent patent applications in epigenetics p353 doi:10.1038/nbt.3205
|
 |
News and Views | Top |
 |
 |
 |
|
 |
News | Top |
 |
 |
 |
Research Highlights p359 doi:10.1038/nbt.3197
|
 |
Computational Biology | Top |
 |
 |
 |
Commentary |
 |
 |
 |
Federalist principles for healthcare data networks pp360 - 363 Kenneth D Mandl and Isaac S Kohane doi:10.1038/nbt.3180 Applying federalist principles to networked health record data could facilitate realization of the potential of shared health data.
|
 |
 |
 |
Analysis |
 |
 |
 |
Large-scale imputation of epigenomic datasets for systematic annotation of diverse human tissues OPEN pp364 - 376 Jason Ernst and Manolis Kellis doi:10.1038/nbt.3157 Large-scale epigenomic profiles are predicted from experimental data using multiple regression tree models.
See also: News and Views by Ebert & Bock
|
 |
Research | Top |
 |
 |
 |
Article |
 |
 |
 |
Distributing a metabolic pathway among a microbial consortium enhances production of natural products pp377 - 383 Kang Zhou, Kangjian Qiao, Steven Edgar and Gregory Stephanopoulos doi:10.1038/nbt.3095 Dividing a metabolic pathway between yeast and Escherichia coli enables synthesis of a small molecule.
|
 |
 |
 |
Letters |
 |
 |
 |
High-throughput fluorescence correlation spectroscopy enables analysis of proteome dynamics in living cells pp384 - 389 Malte Wachsmuth, Christian Conrad, Jutta Bulkescher, Birgit Koch, Robert Mahen et al. doi:10.1038/nbt.3146 Automated fluorescence correlation spectroscopy data acquisition and analysis allows high throughput analysis of protein dynamics in cells.
See also: News and Views by Teruel et al.
|
 |
 |
 |
Inducible in vivo genome editing with CRISPR-Cas9 pp390 - 394 Lukas E Dow, Jonathan Fisher, Kevin P O'Rourke, Ashlesha Muley, Edward R Kastenhuber et al. doi:10.1038/nbt.3155 Mouse lines with an inducible Cas9 gene enable in vivo disease modeling.
|
 |
 |
 |
ChIP-nexus enables improved detection of in vivo transcription factor binding footprints pp395 - 401 Qiye He, Jeff Johnston and Julia Zeitlinger doi:10.1038/nbt.3121 Nucleotide-resolution mapping of transcription factor binding sites with an optimized ChIP-exo method reveals effects of local DNA sequence.
|
 |
 |
 |
Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice pp402 - 407 Matthias Obenaus, Catarina Leitao, Matthias Leisegang, Xiaojing Chen, Ioannis Gavvovidis et al. doi:10.1038/nbt.3147 A humanized mouse model facilitates the identification of T cell receptors for unmutated cancer antigens.
|
 |
 |
 |
Resources |
 |
 |
 |
Resequencing 302 wild and cultivated accessions identifies genes related to domestication and improvement in soybean OPEN pp408 - 414 Zhengkui Zhou, Yu Jiang, Zheng Wang, Zhiheng Gou, Jun Lyu et al. doi:10.1038/nbt.3096 Resequencing of 302 soybean accessions and GWAS provide a comprehensive resource for soybean geneticists and breeders.
|
 |
 |
 |
Acetylation site specificities of lysine deacetylase inhibitors in human cells pp415 - 423 Christian Scholz, Brian T Weinert, Sebastian A Wagner, Petra Beli, Yasuyuki Miyake et al. doi:10.1038/nbt.3130 Comprehensive analysis of changes in protein acetylation in response to lysine deacetylase inhibitors uncovers inhibitor specificities.
|
 |
 |
 |
Corrigendum |
 |
 |
 |
Corrigendum: Network deconvolution as a general method to distinguish direct dependencies in networks p424 Soheil Feizi, Daniel Marbach, Muriel Medard and Manolis Kellis doi:10.1038/nbt0415-424
|
 |
Careers and Recruitment | Top |
 |
 |
 |
Expanding ELSI to all areas of innovative science and technology pp425 - 426 Dov Greenbaum doi:10.1038/nbt.3193 New curricula in the study of the ethical, legal and social implications of scientific research aims to further the conversation among all stakeholders in the interactions between science, technology and society.
|
 |
 |
 |
People |
 |
 |
 |
People p428 doi:10.1038/nbt.3203
|
 |
 |
Advertisement |
 |
Complimentary print subscriptions to Nature Reviews Drug Discovery are available in the US, Canada and Europe and are provided to individuals involved in drug discovery and development.
Find out if you qualify now! | | | |
 |
|
 |  |  |  |  |  | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com |  |  |  |  |  |
|
 |
No comments:
Post a Comment